Identification of a Feline Leukemia Virus Variant That Can Use THTR1, FLVCR1, and FLVCR2 for Infection (cid:1)
暂无分享,去创建一个
C. Tailor | B. Willett | Z. Shalev | S. Duffy | K. Adema | Naveen Hussain | Rati Prasad
[1] J. Dick,et al. Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis , 2008, Haematologica.
[2] B. Willett,et al. A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction , 2008, Retrovirology.
[3] J. Abkowitz,et al. A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis , 2008, Science.
[4] J. Overbaugh,et al. A Putative Thiamine Transport Protein Is a Receptor for Feline Leukemia Virus Subgroup A , 2006, Journal of Virology.
[5] C. Tailor,et al. Comprehensive Mapping of Receptor-Functioning Domains in Feline Leukemia Virus Subgroup C Receptor FLVCR1 , 2006, Journal of Virology.
[6] M. Sitbon,et al. Human T Cell Leukemia Virus Envelope Binding and Virus Entry Are Mediated by Distinct Domains of the Glucose Transporter GLUT1* , 2005, Journal of Biological Chemistry.
[7] J. Abkowitz,et al. Identification of a Human Heme Exporter that Is Essential for Erythropoiesis , 2004, Cell.
[8] V. Ganapathy,et al. SLC19: the folate/thiamine transporter family , 2004, Pflügers Archiv.
[9] D. Lavillette,et al. Cell surface receptors for gammaretroviruses. , 2003, Current topics in microbiology and immunology.
[10] R. K. Murthy,et al. Reassessing the Role of Region A in Pit1-Mediated Viral Entry , 2002, Journal of Virology.
[11] J. Overbaugh,et al. Receptors and Entry Cofactors for Retroviruses Include Single and Multiple Transmembrane-Spanning Proteins as well as Newly Described Glycophosphatidylinositol-Anchored and Secreted Proteins , 2001, Microbiology and Molecular Biology Reviews.
[12] J. Overbaugh,et al. Identification of Envelope Determinants of Feline Leukemia Virus Subgroup B That Permit Infection and Gene Transfer to Cells Expressing Human Pit1 or Pit2 , 2001, Journal of Virology.
[13] C. Tailor,et al. Cellular and Species Resistance to Murine Amphotropic, Gibbon Ape, and Feline Subgroup C Leukemia Viruses Is Strongly Influenced by Receptor Expression Levels and by Receptor Masking Mechanisms , 2000, Journal of Virology.
[14] J Overbaugh,et al. Identification of a cellular cofactor required for infection by feline leukemia virus. , 2000, Science.
[15] J Overbaugh,et al. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. , 2000, Blood.
[16] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[17] J Overbaugh,et al. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors. , 1998, Virology.
[18] I. Paulsen,et al. Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.
[19] J. Albert,et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype , 1997, Journal of virology.
[20] A. Trkola,et al. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex , 1997, Journal of virology.
[21] R. Connor,et al. Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.
[22] Marc Parmentier,et al. A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.
[23] Y Takeuchi,et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum , 1995, Journal of virology.
[24] A. Kingsman,et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.
[25] C. Barbas,et al. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120 , 1995, Journal of virology.
[26] J. Neil,et al. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. , 1994, The Journal of general virology.
[27] R. Sheets,et al. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas , 1993, Journal of virology.
[28] J. Neil,et al. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. , 1992, The Journal of general virology.
[29] J. Mullins,et al. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] Y Takeuchi,et al. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus , 1992, Journal of virology.
[31] A. Miller,et al. Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor , 1992, Journal of virology.
[32] E A Hoover,et al. Feline leukemia virus infection and diseases. , 1991, Journal of the American Veterinary Medical Association.
[33] O. Danos,et al. Retroviral-mediated gene transfer into hepatocytes in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Mullins,et al. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS , 1991, Journal of virology.
[35] J. Abkowitz,et al. Retrovirus-induced feline pure red blood cell aplasia: pathogenesis and response to suramin. , 1991, Blood.
[36] J. Neil,et al. Feline leukaemia virus: generation of pathogenic and oncogenic variants. , 1991, Current topics in microbiology and immunology.
[37] J. Mullins,et al. Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus. , 1989, Leukemia research.
[38] J. Mullins,et al. Transduction of endogenous envelope genes by feline leukaemia virus in vitro , 1988, Nature.
[39] J. Mullins,et al. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. , 1988, Science.
[40] C. K. Grant,et al. Retrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complement. , 1987, The Journal of clinical investigation.
[41] J. Mullins,et al. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma , 1986, Journal of virology.
[42] J. Mullins,et al. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses , 1986, Journal of virology.
[43] D. Onions,et al. Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia , 1984, International journal of cancer.
[44] D. Onions,et al. Selective effect of feline leukaemia virus on early erythroid precursors , 1982, Nature.
[45] O. Jarrett,et al. Determinants of the host range of feline leukaemia viruses. , 1973, The Journal of general virology.
[46] P S Sarma,et al. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. , 1973, Virology.